Terumo (OTCMKTS:TRUMY) Shares Gap Up – What’s Next?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped up before the market opened on Tuesday. The stock had previously closed at $14.65, but opened at $15.81. Terumo shares last traded at $15.23, with a volume of 1,310 shares traded.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Zacks Research raised Terumo from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 13th. Two equities research analysts have rated the stock with a Strong Buy rating. According to MarketBeat, Terumo presently has an average rating of “Strong Buy”.

Terumo Stock Down 0.5%

The stock has a fifty day moving average price of $15.01 and a two-hundred day moving average price of $14.27. The company has a market cap of $22.31 billion, a price-to-earnings ratio of 21.41 and a beta of 0.77. The company has a quick ratio of 1.37, a current ratio of 2.19 and a debt-to-equity ratio of 0.13.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, August 7th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.44%. The business had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.84 billion. As a group, sell-side analysts expect that Terumo Corp. will post 0.86 EPS for the current year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells medical devices and healthcare products. Its offerings support hospitals, physicians and other healthcare providers across areas including cardiovascular care, interventional procedures, blood management, cell and gene therapies, and general medical care.

The company’s products include catheters, guidewires, stents and other devices used in cardiovascular and endovascular procedures, as well as blood bags, apheresis systems, cell-processing technologies, infusion and injection products, and hospital equipment.